Physician profile
Ginger E Holt
NPI 1790850600
$341.49
in general payments reported to CMS, 2019-2025
9 companies · $78.69 in 2025
The $78.69 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.43 · 2021: $18.87 · 2024: $215 · 2025: $78.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Illuminoss Medical, INC. | $139.84 | 2024 | |
| Integra Lifesciences Corporation | $50.33 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Depuy Synthes Sales INC. | $29.43 | 2019 | |
| Smith+Nephew, INC. | $26.64 | 2024 | Oasis, Stravix |
| Medtronic, INC. | $23.67 | 2025 | Plasmablade(Tm) |
| Access Pro Medical, LLC | $22.69 | 2025 | Matriderm |
| Stryker Corporation | $18.87 | 2021 | |
| Acera Surgical, INC. | $18.38 | 2024 | Restrata Wound Matrix |
| Kerecis Limited | $11.64 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginger Holt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.